Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bionic hand gets a sense of touch: new device aims to make prosthetics feel like part of the body

NCT ID NCT07418645

Symptom relief Sponsor: University of Pisa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a device that gives pressure and vibration feedback to people using a bionic hand after losing an arm below the elbow. The goal is to see if this feedback helps users feel more ownership and control over the prosthetic, making it easier to use in everyday tasks. Nine participants will try the device in two phases: first in a rubber hand illusion experiment, then while performing daily activities with the actual prosthesis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PULSE device (pressure and vibrotactile feedback system integrated into a prosthetic limb)
What this could lead to
If successful, this could make prosthetic hands feel more natural and easier to control, improving daily life for people with upper-limb amputations.
What could go wrong
This is a very small pilot study with only 9 participants, so results may not apply to everyone. The feedback might also feel confusing or uncomfortable for some users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 9 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Presence of a stump at the transradial level * Active lifestyle (i.e., K-level K4, according to Medicare functional level classification) * Ability to understand and provide Informed Consent to participate in the study - Ability to participate in experimental acquisitions Exclusion Criteria: * Bilateral transradial amputation * Learning disabilities * Inability to understand the informed consent form * History or evidence of any medical, neurological or psychiatric conditions, which may affect brain function, metabolism, balance or motion, perception, representing, thus, a contraindication to the study (also stump pain or tenderness), other than the medical conditions or pathologies that have caused the upper-limb amputation * Hypertension, cardiovascular disease, and other endocrine diseases, neuromuscular diseases, malignancies * Vision and/or hearing problems severe enough to interfere with experimental procedures * Carrier of infectious diseases * Alcoholism or other substance abuse

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amputees are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Amputees

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Neurorehabilitation, Univeristy Hospital of Pisa

    RECRUITING

    Pisa, PI, 56124, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.